Skip to main content
letter
. 2020 Aug 30;120(12):1716–1719. doi: 10.1055/s-0040-1715836

Fig. 1.

Fig. 1

CRP peak, fibrinogen peak, acute pulmonary embolism, and extent of coronavirus disease 2019 (COVID-19) disease on chest CT according to the three stages COVID-19-associated hemostatic abnormalities (CAHA) classification. The extent of COVID-19 disease on chest CT was assessed as pulmonary injuries extension in percentage of the total pulmonary field and classified as minimal (stage 1 < 10%), moderate (stage 2 = 10–25%), severe (stage 3 = 25–50%), and critical (stage 4 > 50%). APE, acute pulmonary embolism; CRP, C-reactive protein; CT, computed tomography; ULN, upper limit of normal.